Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756855 · ClinicalTrials.gov registry record · NA
Young Adults With Violent Behavior During Early Psychosis (Aim 2)
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by Columbia University.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05756855: Active NA study of Schizophrenia and Schizoaffective Disorder, sponsored by Columbia University.
NCT05756855 is a NA study of Schizophrenia and Schizoaffective Disorder that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 15 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05756855, a NA study of Schizophrenia and Schizoaffective Disorder, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.
Primary Outcome
The AIM is a 4-item measure of the acceptability of the intervention, to be completed by EIS clinicians. Scores range from 1-4 with higher score indicating high acceptability.
Conditions Studied
Interventions
- BEHAVIORAL adapted behavioral intervention
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-03-19 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05756855 still lists
NCT05756855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (93% lower).
The record links to 5 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which adapted behavioral intervention is the first listed.
NCT05756855 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05756855 about?
NCT05756855 is a clinical study titled "Young Adults With Violent Behavior During Early Psychosis (Aim 2)". This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.
What is the current status of trial NCT05756855?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-03-19. Estimated completion is 2026-08-31.
What conditions does trial NCT05756855 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Delusional Disorder, Other Specified Schizophrenia Spectrum and Other Psychotic Disorder.
What interventions are being tested in trial NCT05756855?
The interventions under investigation include: adapted behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05756855?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05756855 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05756855's enrollment target sits among peer trials
15 301st of 315 higher than 13 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI